IP Library Granted Patent US 12,360,125
Granted Patent B2
US 12,360,125 · App. 16/319,412 · Granted Jul 15, 2025

Biosensor for coagulation testing

Inventors: Florian Bell (Bend, OR); Bruce Murdock (Bend, OR)
Assignee: Zomedica Biotechnologies LLC
G01N33/86B01L3/502715G01N11/10G01N11/16G01N15/0637G01N29/022G01N29/036G01N29/222G01N30/96G01N33/4905B01L2300/023B01L2300/0636B01L2300/0816B01L2300/0867B01L2400/0436G01N2015/0092G01N15/01G01N2203/0089G01N2203/0092G01N2291/02466G01N2291/0255G01N2291/0256G01N2291/02818G01N2291/0426G01N2291/106
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,360,125
App. No.
16/319,412
Filed
Jan 21, 2019
Granted
Jul 15, 2025
Kind
B2
Art Unit
1796
USPC
435/13
Abstract

Sensors employing bulk acoustic wave (BAW) resonators are used to assay characteristics of blood. The BAW sensors may be used to sense viscosity of a sample comprising blood to determine coagulation properties of the blood. The viscosity of the blood may be evaluated in the presence of agents that inhibit coagulation or that promote coagulation. The change in viscosity of the sample in the presence of such agents may provide information regarding whether the blood suffers from a coagulation disorder.

Claims (39)

1. A method of measuring coagulation properties of blood in a sample over a period of time, the method comprising:

driving a first bulk acoustic wave (BAW) resonator, a second bulk acoustic wave (BAW) resonator, and a third bulk acoustic wave (BAW) resonator, each comprising a sensing surface, into an oscillating motion;

flowing the sample through a flow path comprising the first, second, and third bulk acoustic wave (BAW) resonators, wherein the flow path comprises two or more branches arranged in parallel with one another, wherein at least two of the two or more branches each include at least one BAW resonator; and

detecting a resonance characteristic of each oscillating BAW resonator while the sample is in contact with the sensing surface, wherein the resonance characteristic of the first BAW resonator is detected at a first time point, and the second BAW resonator detects a resonance characteristic at a second time point in sequence after the first time point.

2. The method of claim 1 , wherein the first BAW resonator is adapted to measure a viscosity of the sample;

wherein the second BAW resonator (i) is adapted to measure the viscosity of the sample or (ii) comprises a biomolecule on the sensing surface of the second BAW resonator that specifically binds to a component or molecule of the blood in the sample; and

wherein the third BAW resonator (i) is adapted to measure the viscosity of the sample or (ii) comprises a biomolecule on the sensing surface of the third BAW resonator that specifically binds to a component or molecule of the blood in the sample.

3. The method of 2 , further comprising:

converting the resonance characteristic of the first BAW resonator into a value indicating the viscosity of the sample;

converting the resonance characteristic of the second BAW resonator (i) into a value indicating the viscosity of the sample or (ii) into a concentration of the component or molecule of the blood in the sample;

detecting a resonance characteristic at the third BAW resonator, and converting the resonance characteristic of the third BAW resonator (i) into a value indicating the viscosity of the sample or (ii) into a concentration of the component or molecule of the blood in the sample; and

using the value indicating the viscosity of the sample and the concentration of the component or molecule of the blood in the sample to measure the coagulation properties of the blood in the sample.

4. The method of claim 3 , further comprising mixing the sample with a coagulation-modifying agent prior to flowing the sample across the sensing surface of the first BAW resonator, the second BAW resonator, the third BAW resonator, or any combination thereof.

5. The method of claim 4 , wherein the coagulation-modifying agent comprises a coagulation inhibitor.

6. The method of claim 5 , further comprising using the viscosity of the sample from the first BAW resonator, the second BAW resonator, or any combination thereof, to determine an appropriate dosage of the coagulation inhibitor to provide to a patient for whom coagulation inhibitor therapy is indicated.

7. The method of claim 4 , further comprising mixing the sample with a plurality of coagulation-modifying agents or combinations thereof and determining the effect of the coagulation-modifying agents or combinations thereof on the coagulation properties of the blood in the sample.

8. The method of claim 4 , wherein the coagulation-modifying agent comprises a platelet activator.

9. The method of claim 1 , wherein the first, second, or third BAW resonators, or any combination thereof, are arranged in series.

10. The method of claim 1 , wherein the first, second, and third BAW resonators, or any combination thereof, are arranged in an array.

11. The method of claim 1 , further comprising detecting a resonance characteristic of an isolated environmental BAW reference resonator that does not come in contact with the sample.

12. The method of claim 2 , further comprising comparing the viscosity measured from the first BAW resonator with the viscosity measured from the second BAW resonator when the second BAW resonator is adapted to measure the viscosity of the sample, the third BAW resonator when the third BAW resonator is adapted to measure the viscosity of the sample, or both.

13. The method of claim 1 , further comprising flowing the sample across the sensing surface of the first BAW resonator before flowing the sample across the sensing surface of the third BAW resonator.

14. The method of claim 13 , further comprising flowing the sample across the sensing surface of the second BAW resonator before flowing the sample across the sensing surface of the third BAW resonator.

15. The method of claim 1 , further comprising agitating at least a portion of the sample.

16. The method of claim 15 , wherein agitating at least a portion of the sample comprises active agitation or passive agitation.

17. The method of claim 16 , wherein agitating at least a portion of the sample comprises passive agitation comprising placement of one or more features or valves in the flow path to cause turbulent flow.

18. A method of measuring coagulation properties of blood in a sample, the method comprising:

driving a first bulk acoustic wave (BAW) resonator, a second bulk acoustic wave (BAW) resonator, and a third bulk acoustic wave (BAW) resonator, each comprising a sensing surface, into an oscillating motion;

flowing the sample through a flow path comprising the first, second, and third bulk acoustic wave (BAW) resonators;

detecting a resonance characteristic of each oscillating BAW resonator while the sample is in contact with the sensing surface; and

agitating at least a portion of the sample, wherein:

a first portion of the sample is not agitated before flowing the first portion of the sample across the sensing surface of the first BAW resonator;

a second portion of the sample is agitated before flowing the second portion of the sample across the sensing surface of the second BAW resonator; and

a third portion of the sample is agitated before flowing the third portion of the sample across the sensing surface of the third BAW resonator.

19. The method of claim 18 , wherein the second portion of the sample is agitated to a different degree than the third portion of the sample.

20. A method of measuring coagulation properties of blood in a sample, the method comprising:

driving a first bulk acoustic wave (BAW) resonator, a second bulk acoustic wave (BAW) resonator, and a third bulk acoustic wave (BAW) resonator, each comprising a sensing surface, into an oscillating motion;

flowing the sample through a flow path comprising the first, second, and third bulk acoustic wave (BAW) resonators, wherein the flow path comprises two or more branches arranged in parallel with one another, wherein at least two of the two or more branches each include at least one BAW resonator; and

detecting a resonance characteristic of each oscillating BAW resonator while the sample is in contact with the sensing surface.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2023
From: QORVO US, INC.
To: QORVO BIOTECHNOLOGIES, LLC
Reel/Frame 065891/0500 →
CHANGE OF NAME Recorded Dec 16, 2023
From: QORVO BIOTECHNOLOGIES, LLC
To: ZOMEDICA BIOTECHNOLOGIES LLC
Reel/Frame 066047/0683 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2023
From: QORVO US, INC.
To: QORVO BIOTECHNOLOGIES, LLC
Reel/Frame 065124/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2019
From: BELL, FLORIAN; MURDOCK, BRUCE
To: QORVO US, INC.
Reel/Frame 048227/0429 →
Continuity (3)
Provisional Application 62366578 · Jul 25, 2016
Related Publication 20190250176A1 · Aug 15, 2019
Related Publication 20200256881A9 · Aug 13, 2020
References Cited (31)
US 4640756A · Wang et al. · 1987 [cited by applicant]
US 5798452A · Martin et al. · 1998 [cited by applicant]
US 8409875B2 · Johal et al. · 2013 [cited by applicant]
US 9922809B2 · McCarron et al. · 2018 [cited by applicant]
US 20040150296A1 · Park · 2004 [cited by examiner]
US 20070244520A1 · Ferren · 2007 [cited by examiner]
US 20090025459A1 · Zhang · 2009 [cited by examiner]
US 20120100636A1 · Johal et al. · 2012 [cited by applicant]
US 20120195797A1 · Sparks et al. · 2012 [cited by applicant]
US 20120297859A1 · Yu et al. · 2012 [cited by applicant]
US 20170110300A1 · McCarron et al. · 2017 [cited by applicant]
WO WO2014143680A · 2014 [cited by applicant]
WO 2018022758A1 · 2018 [cited by applicant]
WO WO2018022620A1 · 2018 [cited by applicant]
WO WO2018022757A · 2018 [cited by applicant]
WO WO2018022778A · 2018 [cited by applicant]
Voiculescu, I., et al., “Acoustic wave based MEMS devices for biosensing applications,” 2012, Biosensors and Bioelectronics, 33(1): 1-9. (Year: 2012). [cited by examiner]
U.S. Appl. No. 62/366,578, filed Jul. 25, 2016, Bell et al. [cited by applicant]
U.S. Appl. No. 62/368,261, filed Jul. 29, 2016, Edwards et al. [cited by applicant]
U.S. Appl. No. 62/370,788, filed Aug. 4, 2016, Bell et al. [cited by applicant]
PCT/US2017/043732, Jul. 25, 2017, Bell et al. [cited by applicant]
PCT/US2017/043958, Jul. 26, 2017, Bell et al. [cited by applicant]
PCT/US2017/043992, Jul. 26, 2017, Edwards et al. [cited by applicant]
International Patent Application No. PCT/US2017/043732, filed Jul. 25, 2017; International Search Report / Written Opinion issued Nov. 27, 2017; 11 pages. [cited by applicant]
International Patent Application No. PCT/US2017/043732, filed Jul. 25, 2017; International Preliminary Report on Patentability issued Feb. 7, 2019; 23 pages. [cited by applicant]
Kanazawa, K. Keiji, et al., “Frequency of a Quartz Microbalance in Contact with Liquid,” 1985, [cited by applicant]
Lei et al., “Real-Time Electrical Impedimetric Monitoring of Blood Coagulation Process under Temperature and Hematocrit Variations Conducted in a Microfluidic Chip,” Oct. 2013, [cited by applicant]
Martin, Stephen J., et al., “Characterization of a Quartz Crystal Microbalance with Simultaneous Mass and Liquid Loading,” 1991, [cited by applicant]
Martin et al., “Equivalent-Circuit Model for the Thickness-Shear Mode Resonator with a Viscoelastic Film near Film Resonance,” Oct. 20, 1999, Microsensor Research and Development Department, Sandia National Laboratories… [cited by applicant]
Martin, Stephen J., et al., “Equivalent-Circuit Model for the Thickness-Shear Mode Resonator with a Viscoelastic Film Near Film Resonance,” 2000, [cited by applicant]
Yang, C-L, et al., “Design and Evaluation of a Portable Optical-Based Biosensor for Testing Whole Blood Prothrombin Time,” Talanta, vol. 116, Nov. 15, 2013, pp. 704-711. [cited by applicant]